canSAR: update to the cancer translational research and drug discovery knowledgebase

Patrizio Di Micco, Albert A. Antolin, Costas Mitsopoulos, Eloy Villasclaras-Fernandez, Domenico Sanfelice, Daniela Dolciami, Pradeep Ramagiri, Ioan L. Mica, Joseph E. Tym, Philip W. Gingrich, Huabin Hu, Paul Workman, Bissan Al-Lazikani

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

canSAR (https://cansar.ai) is the largest public cancer drug discovery and translational research knowledgebase. Now hosted in its new home at MD Anderson Cancer Center, canSAR integrates billions of experimental measurements from across molecular profiling, pharmacology, chemistry, structural and systems biology. Moreover, canSAR applies a unique suite of machine learning algorithms designed to inform drug discovery. Here, we describe the latest updates to the knowledgebase, including a focus on significant novel data. These include canSAR's ligandability assessment of AlphaFold; mapping of fragment-based screening data; and new chemical bioactivity data for novel targets. We also describe enhancements to the data and interface.

Original languageEnglish (US)
Pages (from-to)D1212-D1219
JournalNucleic acids research
Volume51
Issue numberD1
DOIs
StatePublished - Jan 6 2023

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'canSAR: update to the cancer translational research and drug discovery knowledgebase'. Together they form a unique fingerprint.

Cite this